According to a new study, continuous glucose monitoring is connected to reduced type and number of episodes of hypoglycemia among individuals with type 1 diabetes. This 69-week clinical trial involved 161 participants with type 1 diabetes, and each was treated with multiple daily injections of insulin. From this cohort, some participants used continuous glucose monitoring, while others engaged in self-measurement.
Researchers found that the continuous glucose monitoring group had an increased confidence in their ability to avoid serious hypoglycemia-related problems compared to the self-measurement group. They also spent less time with both nocturnal and daytime hypoglycemia, and they felt better able to manage their hypoglycemia in social situations.
These findings were published in Diabetes Technology & Therapeutics on April 1, 2018.